Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Exchange Rate Effect (2023 - 2025)

Historic Exchange Rate Effect for Ironwood Pharmaceuticals (IRWD) over the last 3 years, with Q3 2025 value amounting to -$26000.0.

  • Ironwood Pharmaceuticals' Exchange Rate Effect changed 0.0% to -$26000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was -$659000.0, marking a year-over-year decrease of 53980.58%. This contributed to the annual value of -$32000.0 for FY2024, which is 3962.26% up from last year.
  • Per Ironwood Pharmaceuticals' latest filing, its Exchange Rate Effect stood at -$26000.0 for Q3 2025, which was down 0.0% from -$647000.0 recorded in Q2 2025.
  • Ironwood Pharmaceuticals' Exchange Rate Effect's 5-year high stood at $24000.0 during Q1 2024, with a 5-year trough of -$647000.0 in Q2 2025.
  • Its 3-year average for Exchange Rate Effect is -$95250.0, with a median of -$26000.0 in 2024.
  • Its Exchange Rate Effect has fluctuated over the past 5 years, first skyrocketed by 14200.0% in 2024, then plummeted by 116862.75% in 2025.
  • Over the past 3 years, Ironwood Pharmaceuticals' Exchange Rate Effect (Quarter) stood at -$50000.0 in 2023, then surged by 142.0% to $21000.0 in 2024, then plummeted by 223.81% to -$26000.0 in 2025.
  • Its last three reported values are -$26000.0 in Q3 2025, -$647000.0 for Q2 2025, and -$7000.0 during Q1 2025.